Table 1 Demographic characteristics and biochemical data for patients with impaired fasting glucose (IFG), patients with impaired glucose tolerance (IGT), and control subjects
IFG (n = 29) | IGT (n = 29) | Control (n = 28) | p | |
|---|---|---|---|---|
Gender, n (%) | ||||
Female | 23 (79.3) | 23 (79.3) | 23 (82.1) | 0.953 |
Male | 6 (20.7) | 6 (20.7) | 5 (17.9) | |
Age (Years), mean ± SD | 45.2 ± 10.3 | 46.9 ± 10.4 | 44.2 ± 8.1 | 0.575 |
BMI (kg/m 2 ), mean ± SD | 27.9 ± 2.4 | 28.6 ± 3.6 | 28.6 ± 4.1 | 0.652 |
Waist/hip ratio, mean ± SD | 0.90 ± 0.07 | 0.87 ± 0.07 | 0.85 ± 0.08 | 0.047 |
Hypertension, n (%) | ||||
Absent | 28 (96.6) | 27 (93.1) | 28 (100.0) | 0.770 |
Present | 1 (3.4) | 2 (6.9) | 0 (0) | |
Smoking, n (%) | ||||
Absent | 26 (89.7) | 24 (82.8) | 25 (89.3) | 0.784 |
Present | 3 (10.3) | 5 (17.2) | 3 (10.7) | |
Total cholesterol level (mg/dL), mean ± SD | 184.9 ± 27.2 | 187.6 ± 34.9 | 198.1 ± 23.3 | 0.110 |
LDL level (mg/dL), mean ± SD | 117.7 ± 40.3 | 105.9 ± 32.6 | 118.2 ± 23.7 | 0.204 |
HDL level (mg/dL), mean ± SD memean ± SD | 47.9 ± 10.2 | 52.2 ± 27.3 | 51.3 ± 11.7 | 0.533 |
TG level (mg/dL), mean ± SD | 120.9 ± 38.9 | 148.0 ± 68.9 | 131.6 ± 48.2 | 0.364 |
Fasting blood glucose level (mg/dL), mean ± SD | 111.1 ± 5.9 | 105.1 ± 8.5 | 92.3 ± 5.0 | <0.001 |
Insulin level, mean ± SD | 11.9 ± 4.8 | 13.1 ± 5.4 | 9.10 ± 4.2 | 0.008 |
HOMA-IR level, mean ± SD | 3.4 ± 1.4 | 4.1 ± 1.7 | 2.1 ± 1.0 | <0.001 |